Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-25-116084
Filing Date
2025-11-25
Accepted
2025-11-25 18:59:54
Documents
1
Period of Report
2025-11-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2532217-1_4aseq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2532217-1_4aseq1.xml 4/A 8852
  Complete submission text file 0001104659-25-116084.txt   10452
Mailing Address 1 GREENWICH OFFICE PARK ONE LAFAYETTE PLACE GREENWICH FL 06831
Business Address (203) 413-2200
Hoffman Michael B (Reporting) CIK: 0001290208 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39202 | Film No.: 251523148

Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)